Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-23-032250

Chief Medical Officer gave up 2,527 shares (to pay taxes)

  • Chief Medical Officer acquired 6,938 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Morrow Phuong Khanh Chief Medical Officer 2023-05-23 Option exercise +6,938 6,938 D
Morrow Phuong Khanh Chief Medical Officer 2023-05-24 Shares withheld for taxes −2,527 $65.91 $166,555 4,411 D
Derivatives
Morrow Phuong Khanh Chief Medical Officer 2023-05-23 Option exercise · Restricted Stock Units +6,938 20,812 D
Loading xslF345X04/doc4.xml…